Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SkyePharma has licensed its US food and Drug Administration (FDA) approved pharma manufacturing plant established in Lyon, France to Aenova Group.
Subscribe to our email newsletter
The plant offers capacity and capability for the manufacture of several solid dosage forms.
In addition to standard manufacturing capabilities, the facility offers advanced tablet production: bi-layer, tri-layer, and core/coating, granulation/drying: large capacity up to 1,200 litre with multiple lines and microfluidisation and large capacity pan coating.
Under the agreement, Aenova is responsible to pay rental to SkyePharma for using the plant for two years.
The two years agreement is extendable for a further three years.
By introducing additional products to the facility, the agreement aims to increase utilization rates and reduce the dependency on relatively few products and the risk of losses in the pharmaceutical manufacturing business.